An increase in the expression of circulating miR30d-5p and miR126-3p is associated with intermediate hyperglycaemia in Iranian population

References

• Aghaei, M., et al., 2020. Major miRNA involved in insulin secretion and production in beta-cells. International journal of general medicine, 13, 89–97.
   PubMed Web of Science ®Google Scholar
• Arner, E., et al., 2012. Adipose tissue microRNAs as regulators of CCL2 production in human obesity. Diabetes, 61 (8), 1986–1993.
   PubMed Web of Science ®Google Scholar
• Arroyo, J.D., et al., 2011. Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proceedings of the national academy of sciences of the United States of America, 108 (12), 5003–5008.
   PubMed Web of Science ®Google Scholar
• Bartel, D.P., 2004. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell, 116 (2), 281–297.
   PubMed Web of Science ®Google Scholar
• Bartel, D.P., 2009. MicroRNAs: target recognition and regulatory functions. Cell, 136 (2), 215–233.
   PubMed Web of Science ®Google Scholar
• Berezin, A., 2016. Metabolic memory phenomenon in diabetes mellitus: achieving and perspectives. Diabetes & metabolic syndrome, 10 (2 Suppl 1), S176–S183.
   PubMed Web of Science ®Google Scholar
• Brannick, B., Wynn, A., and Dagogo-Jack, S., 2016. Prediabetes as a toxic environment for the initiation of microvascular and macrovascular complications. Experimental biology and medicine (Maywood, NJ), 241 (12), 1323–1331.
   PubMed Web of Science ®Google Scholar
• DeFronzo, R.A., et al., 2015. Type 2 diabetes mellitus. Nature reviews disease primers, 1 (1), 1–22.
   Web of Science ®Google Scholar
• Demirsoy, I.H., et al., 2018. Profiles of circulating miRNAs following metformin treatment in patients with type 2 diabetes. Journal of medical biochemistry, 37 (4), 499–506.
   PubMed Web of Science ®Google Scholar
• Diehl, P., et al., 2012. Microparticles: major transport vehicles for distinct microRNAs in circulation. Cardiovascular research, 93 (4), 633–644.
   PubMed Web of Science ®Google Scholar
• Donath, M.Y., and Shoelson, S.E., 2011. Type 2 diabetes as an inflammatory disease. Nature reviews immunology, 11 (2), 98–107.
   PubMed Web of Science ®Google Scholar
• Fish, J.E., et al., 2008. miR-126 regulates angiogenic signaling and vascular integrity. Developmental cell, 15 (2), 272–284.
   PubMed Web of Science ®Google Scholar
• Gatsiou, A., et al., 2012. MicroRNAs in platelet biogenesis and function: implications in vascular homeostasis and inflammation. Current vascular pharmacology, 10 (5), 524–531.
   PubMed Web of Science ®Google Scholar
• Ghorbani, S., et al., 2018. Decreased serum microRNA-21 level is associated with obesity in healthy and type 2 diabetic subjects. Archives of physiology and biochemistry, 124 (4), 300–305.
   PubMed Web of Science ®Google Scholar
• Guay, C., and Regazzi, R., 2013. Circulating microRNAs as novel biomarkers for diabetes mellitus. Nature reviews endocrinology, 9 (9), 513–521.
   PubMed Web of Science ®Google Scholar
• Ha, M., and Kim, V.N., 2014. Regulation of microRNA biogenesis. Nature reviews molecular cell biology, 15 (8), 509–524.
   PubMed Web of Science ®Google Scholar
• Harris, T.A., et al., 2008. MicroRNA-126 regulates endothelial expression of vascular cell adhesion molecule 1. Proceedings of the national academy of sciences of the United States of America, 105 (5), 1516–1521.
   PubMed Web of Science ®Google Scholar
• Huang, R.S., et al., 2011. Population differences in microRNA expression and biological implications. RNA biology, 8 (4), 692–701.
   PubMed Web of Science ®Google Scholar
• Jimenez-Lucena, R., et al., 2018. Circulating miRNAs as predictive biomarkers of type 2 diabetes mellitus development in coronary heart disease patients from the CORDIOPREV study. Molecular therapy - nucleic acids, 12, 146–157.
   Google Scholar
• Kong, L., et al., 2011. Significance of serum microRNAs in pre-diabetes and newly diagnosed type 2 diabetes: a clinical study. Acta diabetologica, 48 (1), 61–69.
   PubMed Web of Science ®Google Scholar
• Li, Y., et al., 2016. Hyperglycemia and advanced glycation end products regulate miR-126 expression in endothelial progenitor cells. Journal of vascular research, 53 (1–2), 94–104.
   PubMed Web of Science ®Google Scholar
• Lin, Y.C., et al., 2020. Early sensory neurophysiological changes in prediabetes. Journal of diabetes investigation, 11 (2), 458–465.
   PubMed Web of Science ®Google Scholar
• Liu, Y., et al., 2014. The role of circulating microRNA-126 (miR-126): a novel biomarker for screening prediabetes and newly diagnosed type 2 diabetes mellitus. International journal of molecular sciences, 15 (6), 10567–10577.
   PubMed Web of Science ®Google Scholar
• Livak, K.J., and Schmittgen, T.D., 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods (San Diego, Calif.), 25 (4), 402–408.
   PubMed Web of Science ®Google Scholar
• Mahat, R.K., et al., 2019. Health risks and interventions in prediabetes: A review. Diabetes & metabolic syndrome, 13 (4), 2803–2811.
   PubMed Web of Science ®Google Scholar
• Miao, C., et al., 2018. MicroRNAs in the pathogenesis of type 2 diabetes: new research progress and future direction. Canadian journal of physiology and pharmacology, 96 (2), 103–112.
   PubMed Web of Science ®Google Scholar
• Misra, A., and Bloomgarden, Z., 2018. Metabolic memory: evolving concepts. Journal of diabetes, 10 (3), 186–187.
   PubMed Web of Science ®Google Scholar
• Nielsen, S., et al., 2014. The miRNA plasma signature in response to acute aerobic exercise and endurance training. PloS One, 9 (2), e87308.
   PubMed Web of Science ®Google Scholar
• Ortega, F.J., et al., 2014. Profiling of circulating microRNAs reveals common microRNAs linked to type 2 diabetes that change with insulin sensitization. Diabetes care, 37 (5), 1375–1383.
   PubMed Web of Science ®Google Scholar
• Pordzik, J., et al., 2019. Significance of circulating microRNAs in diabetes mellitus type 2 and platelet reactivity: bioinformatic analysis and review. Cardiovascular diabetology, 18 (1), 113.
   PubMed Web of Science ®Google Scholar
• Ryu, H.S., et al., 2011. The induction of microRNA targeting IRS-1 is involved in the development of insulin resistance under conditions of mitochondrial dysfunction in hepatocytes. PLoS One, 6 (3), e17343.
   PubMed Web of Science ®Google Scholar
• Saeedi, P., et al., 2019. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes research and clinical practice, 157, 107843.
   PubMed Web of Science ®Google Scholar
• Sebastiani, G., et al., 2017. Circulating microRNAs and diabetes mellitus: a novel tool for disease prediction, diagnosis, and staging? Journal of endocrinological investigation, 40 (6), 591–610.
   PubMed Web of Science ®Google Scholar
• Seyhan, A.A., et al., 2016. Pancreas-enriched miRNAs are altered in the circulation of subjects with diabetes: a pilot cross-sectional study. Scientific reports, 6 (1), 31479.
   PubMedGoogle Scholar
• Tabak, A.G., et al., 2012. Prediabetes: a high-risk state for developing diabetes. Lancet, 379 (9833), 2279–2290.
   PubMed Web of Science ®Google Scholar
• Tang, S.T., et al., 2017. MicroRNA-126 suppresses inflammation in endothelial cells under hyperglycemic condition by targeting HMGB1. Vascular pharmacology, 88, 48–55.
   PubMed Web of Science ®Google Scholar
• Tang, X., et al., 2009. Identification of glucose-regulated miRNAs from pancreatic {beta} cells reveals a role for miR-30d in insulin transcription. RNA (New York, N.Y.), 15 (2), 287–293.
   PubMed Web of Science ®Google Scholar
• Testa, R., et al., 2017. The metabolic memory theory and the early treatment of hyperglycemia in prevention of diabetic complications. Nutrients, 9 (5), 437.
   PubMed Web of Science ®Google Scholar
• Wang, K., et al., 2012. Comparing the MicroRNA spectrum between serum and plasma. PloS One, 7 (7), e41561.
   PubMed Web of Science ®Google Scholar
• Wang, S., et al., 2008. The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis. Developmental cell, 15 (2), 261–271.
   PubMed Web of Science ®Google Scholar
• Wang, S., et al., 2018. MicroRNA-30d preserves pancreatic islet β-cell function through negative regulation of the JNK signaling pathway via SOCS3 in mice with streptozotocin-induced diabetes mellitus. Journal of cellular physiology, 233 (9), 7343–7355.
   PubMed Web of Science ®Google Scholar
• Wang, X., et al., 2014. Determination of 14 circulating microRNAs in Swedes and Iraqis with and without diabetes mellitus type 2. PloS One, 9 (1), e86792.
   PubMed Web of Science ®Google Scholar
• Zampetaki, A., et al., 2010. Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes. Circulation research, 107 (6), 810–817.
   PubMed Web of Science ®Google Scholar
• Zarch, S.M.A., et al., 2020. Molecular biomarkers in diabetes mellitus (DM). Medical journal of the Islamic republic of Iran, 34, 28.
   PubMedGoogle Scholar
• Zhang, T., et al., 2013. Plasma miR-126 is a potential biomarker for early prediction of type 2 diabetes mellitus in susceptible individuals. BioMed research international, 2013, 761617.
   PubMed Web of Science ®Google Scholar
• Zhao, X., et al., 2012. MicroRNA-30d induces insulin transcription factor MafA and insulin production by targeting mitogen-activated protein 4 kinase 4 (MAP4K4) in pancreatic β-cells. Journal of biological chemistry, 287 (37), 31155–31164.
   PubMed Web of Science ®Google Scholar